In the UK 58 women are diagnosed with a gynaecological cancer each day, and 21 will die.
These cancers make up some of the most common and most fatal diseases that women face, but despite this, gynaecological cancer is neither high profile, nor well funded.
One of our main aims is to fund locally based research into gynaecological cancers including ovarian, uterine, cervical and vulvar cancer, principally at the University of Surrey in Guildford, and within the Gynaeoncology Department.
We also collaborate with research at many of the leading teaching and academic institutions around the UK and internationally.
This progressive approach supported by GRACE funding has led to many novel and cutting edge treatment developments for women facing gynaeacological cancer treatment in Surrey, Hampshire and Sussex.